trending Market Intelligence /marketintelligence/en/news-insights/trending/uj0-z4jrcyijdgmxxr0rpw2 content esgSubNav
Log in to other products

Login to Market Intelligence Platform

 /


Looking for more?

Contact Us
In This List

Juniper Pharmaceuticals adds director

COVID-19 Pandemic Likely To Cause US Telemedicine Boom

Gauging Supply Chain Risk In Volatile Times

S&P Global Market Intelligence

Cannabis: Hashing Out a Budding Industry

Segment

IFRS 9 Impairment How It Impacts Your Corporation And How We Can Help


Juniper Pharmaceuticals adds director

Juniper Pharmaceuticals Inc. added Richard Messina to its board.

Messina is the founder, president and CEO of investment banking and financial advisory company The Benchmark Co. LLC.

Boston-based Juniper Pharmaceuticals is a women's health therapeutic company.